Breaking News
5506 - 5520 of 6623 results
Prev
366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442
Next
June 29, 2007
PharmaNet Development Group, Inc. has opened a new Phase I clinic in Toronto, Canada and new offices in Brussels, Belgium and Milan, Italy. The company has also relocated its Zurich, Switzerland office to allow for future growth of its staff.
&q…
Read More »
June 29, 2007
The European Commission granted marketing authorization for Invega, an atypical antipsychotic medication for the treatment of schizophrenia. This once-daily medication is specifically designed to deliver paliperidone—the drug's active ingredien…
Read More »
June 29, 2007
Greg Norden has been named senior vice president and chief financial officer, Wyeth. Mr. Norden previously served as executive vice president and chief financial officer at Wyeth Pharmaceuticals and has been with the company since 1989. He has held p…
Read More »
June 28, 2007
SGS India Ltd.'s Chennai facility has passed an FDA inspection conducted in February 2007. It was both a pre-approval and a GMP inspection. The facility is classified as "acceptable." This was the first FDA inspection of the SGS QC testing…
Read More »
June 28, 2007
Pfizer initiated a Phase III trial to evaluate the safety and efficacy of sunitinib malate, in combination with a standard chemotherapy regimen, in patients with metastatic colorectal cancer (mCRC). Also, new data from a Phase I study showed that sun…
Read More »
June 28, 2007
Progenics Pharmaceuticals and Wyeth achieved positive results from a three-month open-label extension study of subcutaneous methylnaltrexone for the treatment of opioid-induced constipation (OIC) in patients with advanced illness.
Eighty-two OIC pa…
Read More »
June 27, 2007
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. have submitted a sNDA to the FDA for Nexavar for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved for th…
Read More »
June 27, 2007
Merck's NDA for Isentress has been accepted by the FDA. Data in the NDA support the proposed use of Isentress in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-…
Read More »
June 27, 2007
ViroPharma, Inc.'s HCV-796 for hepatitis C virus infection has been granted fast track designation by the FDA. HCV-796, an orally dosed non-nucleoside hepatitis C viral polymerase inhibitor that interferes with the replication of hepatitis C virus (H…
Read More »
June 26, 2007
Abbott and Genentech have formed a collaboration for the global research, development and commercialization of two of Abbott's investigational anti-cancer compounds, ABT-263 and ABT-869. The companies will share further development and commercializat…
Read More »
June 26, 2007
Wyeth has exercised its right to license three bone anabolic drug targets from a 2003 osteoporosis research agreement with Galapagos, resulting in a $1.4 million milestone payment to Galapagos.
This is the second milestone reached in the osteopo…
Read More »
June 26, 2007
John H. Stewart has been named acting president of Purdue Pharma L.P. Mr. Stewart succeeds Michael Friedman who retired as president and chief executive officer after 22 years with the company. Mr. Stewart will focus on leading Purdue Pharma in the U…
Read More »
June 25, 2007
Roche and Toyama Chemical Co. have entered into a licensing agreement for the research, development and commercialization of Toyama's oral rheumatoid arthritis agent T-5224. By inhibiting a specific inflammatory process, T-5224 has the potential to b…
Read More »
June 25, 2007
Under legislation to be introduced in the U.S. Senate, makers of generic drugs would gain the right to market generic versions of biopharmaceutical medicines. The legislation would create a pathway for the FDA to approve generic treatments made throu…
Read More »
June 25, 2007
James M. Saponaro has joined BioStorage Technologies, Inc. (BST) as executive vice president. In this new role, Mr. Saponaro will oversee the company’s sales and marketing, operations, information technology and business development functions.…
Read More »
5506 - 5520 of 6623 results
Prev
366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442
Next
